148 related articles for article (PubMed ID: 22213868)
1. [Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies].
Feng AM; Wei JY; Yu WJ
Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):473-5. PubMed ID: 22213868
[No Abstract] [Full Text] [Related]
2. [Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection].
Sun HL; Zhou X; Shen YF
Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):558-9. PubMed ID: 22338183
[No Abstract] [Full Text] [Related]
3. Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
Baden LR; Katz JT; Fishman JA; Koziol C; DelVecchio A; Doran M; Rubin RH
Transplantation; 2003 Dec; 76(11):1632-7. PubMed ID: 14702539
[TBL] [Abstract][Full Text] [Related]
4. Case collection study of the safety of AmBisome in association with voriconazole in the treatment of patients with invasive fungal infection.
Askari E; Jarque I; Nicolás Franco S; Cáceres Agra JJ
Rev Esp Quimioter; 2010 Dec; 23(4):210-2. PubMed ID: 21191561
[No Abstract] [Full Text] [Related]
5. [Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
Díaz Pedroche C; Cisneros JM; Lumbreras C; Aguado JM;
Rev Esp Quimioter; 2005 Jun; 18(2):149-58. PubMed ID: 16130037
[TBL] [Abstract][Full Text] [Related]
6. Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?
Cherif H; Kalin M; Björkholm M
Eur J Haematol; 2006 Oct; 77(4):288-92. PubMed ID: 16856930
[TBL] [Abstract][Full Text] [Related]
7. Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
Przepiorka D; Buadi FK; McClune B
Pharmacotherapy; 2008 Jan; 28(1):58-63. PubMed ID: 18154475
[TBL] [Abstract][Full Text] [Related]
8. Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.
Cecil JA; Wenzel RP
Expert Rev Hematol; 2009 Jun; 2(3):237-54. PubMed ID: 21082966
[TBL] [Abstract][Full Text] [Related]
9. Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole.
Sili U; Yilmaz M; Ferhanoglu B; Mert A
Clin Infect Dis; 2007 Oct; 45(7):897-8. PubMed ID: 17806057
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and therapeutic analysis of invasive fungal infection in chronic severe hepatitis patients.
Hou Z; Tan D; Liu G; Xie Y; Li C; Xie J; Lu M; Liu Z; Sha X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jun; 35(6):537-42. PubMed ID: 20622324
[TBL] [Abstract][Full Text] [Related]
11. Voriconazole treatment for less-common, emerging, or refractory fungal infections.
Perfect JR; Marr KA; Walsh TJ; Greenberg RN; DuPont B; de la Torre-Cisneros J; Just-Nübling G; Schlamm HT; Lutsar I; Espinel-Ingroff A; Johnson E
Clin Infect Dis; 2003 May; 36(9):1122-31. PubMed ID: 12715306
[TBL] [Abstract][Full Text] [Related]
12. Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
Sagnelli C; Fumagalli L; Prigitano A; Baccari P; Magnani P; Lazzarin A
J Antimicrob Chemother; 2006 Apr; 57(4):796-8. PubMed ID: 16469850
[No Abstract] [Full Text] [Related]
13. Improving outcomes of acute invasive Aspergillus rhinosinusitis in patients with hematologic malignancies or aplastic anemia: the role of voriconazole.
Girmenia C; Pizzarelli G; Pozzi E; Cimino G; Gentile G; Martino P
Haematologica; 2008 Jan; 93(1):159-60. PubMed ID: 18166809
[TBL] [Abstract][Full Text] [Related]
14. [Voriconazole: a new weapon against invasive fungal infections].
Aoun M
Rev Med Brux; 2004 Jun; 25(3):166-71. PubMed ID: 15291449
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole concentrations and outcome of invasive fungal infections.
Miyakis S; van Hal SJ; Ray J; Marriott D
Clin Microbiol Infect; 2010 Jul; 16(7):927-33. PubMed ID: 19845698
[TBL] [Abstract][Full Text] [Related]
16. Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature.
Garbino J; Uckay I; Rohner P; Lew D; Van Delden C
Transpl Int; 2005 May; 18(5):613-8. PubMed ID: 15819812
[TBL] [Abstract][Full Text] [Related]
17. The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review.
Shang ST; Lin JC; Ho SJ; Yang YS; Chang FY; Wang NC
J Microbiol Immunol Infect; 2010 Jun; 43(3):200-6. PubMed ID: 21291847
[TBL] [Abstract][Full Text] [Related]
18. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
Fournier S; Pavageau W; Feuillhade M; Deplus S; Zagdanski AM; Verola O; Dombret H; Molina JM
Eur J Clin Microbiol Infect Dis; 2002 Dec; 21(12):892-6. PubMed ID: 12525928
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series.
Sen P; Gopal L; Sen PR
Retina; 2006 Oct; 26(8):935-9. PubMed ID: 17031296
[TBL] [Abstract][Full Text] [Related]
20. Topical and oral voriconazole in the treatment of fungal keratitis.
Bunya VY; Hammersmith KM; Rapuano CJ; Ayres BD; Cohen EJ
Am J Ophthalmol; 2007 Jan; 143(1):151-3. PubMed ID: 17188052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
